The WTO and India's Pharmaceutical Industry (Patent Protection, TRIPS, and Developing Countries)
Saved in:
Main Authors: | Smriti Dua Khatri (Author), Roshan Kumar Sahu (Author) |
---|---|
Format: | Bog |
Udgivet: |
Frontiers Media S.A.,
2009-08-01T00:00:00Z.
|
Fag: | |
Online adgang: | Connect to this object online. |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|
Lignende værker
-
A proposal for measuring the degree of public health-sensitivity of patent legislation in the context of the WTO TRIPS Agreement
af: Gabriela Costa Chaves, et al.
Udgivet: (2007) -
Improving Access to COVID-19 Vaccines: An Analysis of TRIPS Waiver Discourse among WTO Members, Civil Society Organizations, and Pharmaceutical Industry Stakeholders
af: Jillian Kohler, et al.
Udgivet: (2020) -
Patents and licensing in pharmaceutical industry
af: Katerina Ancevska Netkovska, et al.
Udgivet: (2005) -
Patent Strategy in Pharmaceutical Industry: Are additional patents valuable?
af: Donghi, Monica
Udgivet: (2014) -
Crisis at the WTO Is the Blocking of Appointments to the WTO Appellate Body by the United States Legally Justified?
af: Lehne, Jens
Udgivet: (2019)